Mesenchymal Stromal Cells to Treat Lung and Brain Injury in a Novel Triple-Hit Neonatal Mouse Model of Chronic Lung Disease

间充质基质细胞治疗慢性肺病的新型三重打击新生小鼠模型中的肺和脑损伤

• 批准号: 365459
• 负责人: Lithopoulos Marissa A
• 金额: $ 7.65万
• 依托单位: Ottawa Hospital Research Institute
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-10-01 至 2019-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=365459&lang=en
• 关键词: Bronchopulmonary Dysplasia; Cell Culture; Gene Expression; Immunohistochemistry; Neonatal Brain Injury; Neural Progenitor Cells; Neurobehavioural Tests; Neurodevelopment; Prematurity; Umbilical Cord Mesenchymal Stromal Cells

An estimated 29 000 infants are born premature (<37 weeks) in Canada each year. Infants born extremely premature (<28 weeks) have lungs that are too weak to support their own breathing. The only life-saving option available is to administer oxygen and mec

据估计，加拿大每年有29 000名婴儿早产（<37周）。早产儿（<28周）的肺部太弱，无法支持自己的呼吸。唯一的救命方法就是给他氧气和mec